/C O R R E C T I O N — Sanofi-Aventis Canada Inc./
In the news release, Sanofi's high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose, issued 21-Oct-2025 by Sanofi-Aventis Canada Inc. over CNW, a footnote “*The standard-dose influenza vaccines used in the FLUNITY-HD study were VaxigripTetra (Sanofi) and InfluvacTetra (Viatris). Standard-dose vaccines often serve as the primary influenza prevention option for the […]